Literature DB >> 24637129

Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders.

Sanne Visser1, Wietske Hermes2, Johannes C F Ket3, René H J Otten3, Maria G van Pampus4, Kitty W M Bloemenkamp5, Arie Franx6, Ben W Mol7, Christianne J M de Groot8.   

Abstract

OBJECTIVE: The aim of this study was to investigate which nonclassic cardiovascular biomarkers are associated with persistent endothelial dysfunction after pregnancy in women with a history of hypertensive pregnancy disorders compared with women with uncomplicated pregnancies. STUDY
DESIGN: This was a systematic review and metaanalysis of observational studies. A search was performed in PubMed, Embase, Cochrane, and Cinahl including articles from inception to Feb. 27, 2013. Included were cohort studies and case-control studies. Cases were women with a history of hypertension in pregnancy, control subjects were women with a history of uncomplicated pregnancies. Of the 3136 found, 21 studies on 16 nonclassic cardiovascular biomarkers are described in this review; 12 studies on 5 biomarkers were included in the metaanalysis.
RESULTS: Women with a history of hypertensive pregnancy disorders had a higher homocysteine level compared with women with a history of uncomplicated pregnancies (5 studies; pooled mean difference, 0.77 ng/mL; 95% confidence interval, 0.27-1.26; P < .01). For the other nonclassic cardiovascular biomarkers including markers in areas of inflammation, thrombosis, and angiogenesis, we found no significant differences.
CONCLUSION: This review and metaanalysis showed that women with a history of hypertensive pregnancy disorders have higher homocysteine levels compared with women with a history of uncomplicated pregnancies. These data suggest persistent endothelial alteration after pregnancies complicated by hypertensive disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular risk; hypertensive pregnancy disorders; preeclampsia; pregnancy-induced hypertension

Mesh:

Substances:

Year:  2014        PMID: 24637129     DOI: 10.1016/j.ajog.2014.03.032

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  How does preeclampsia predispose to future cardiovascular disease?

Authors:  Dawn C Scantlebury; Sharonne N Hayes
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

2.  Cardiovascular biomarkers in the years following pregnancies complicated by hypertensive disorders or delivered preterm.

Authors:  Lauren J Tanz; Jennifer J Stuart; Stacey A Missmer; Eric B Rimm; Jennifer A Sumner; Mary A Vadnais; Janet W Rich-Edwards
Journal:  Pregnancy Hypertens       Date:  2018-04-18       Impact factor: 2.899

3.  Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study.

Authors:  Gerbrand A Zoet; Cindy Meun; Laura Benschop; Eric Boersma; Ricardo P J Budde; Bart C J M Fauser; Christianne J M de Groot; Aad van der Lugt; Angela H E M Maas; Karl G M Moons; Jeanine E Roeters van Lennep; Jolien W Roos-Hesselink; Eric A P Steegers; Bas B van Rijn; Joop S E Laven; Arie Franx; Birgitta K Velthuis
Journal:  BMC Womens Health       Date:  2017-08-07       Impact factor: 2.809

Review 4.  Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis.

Authors:  Lisa J Alma; Anouk Bokslag; Angela H E M Maas; Arie Franx; Walter J Paulus; Christianne J M de Groot
Journal:  ESC Heart Fail       Date:  2017-01-30

5.  Early life environment influences the trajectory of post-partum weight loss in adult female rats.

Authors:  C E Aiken; J L Tarry-Adkins; T J Ashmore; S E Ozanne
Journal:  Reprod Biomed Online       Date:  2018-12-12       Impact factor: 3.828

6.  Non-Obstructive Coronary Artery Disease in Women: Current Evidence and Future Directions.

Authors:  Leanna R Smith; Moro O Salifu; Isabel M McFarlane
Journal:  Int J Clin Res Trials       Date:  2020-11-24

Review 7.  Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia.

Authors:  Ana C Palei; Joey P Granger; Frank T Spradley
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

8.  Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Authors:  Henry Adekola; Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.